Abstract BACKGROUND Cardiac troponins I (cTnI) and T (cTnT) have received international
endorsement as the standard biomarkers for detection of myocardial injury, for risk …

Acute myocardial infarction is defined as myocardial cell death due to prolonged myocardial
ischaemia. Cardiac troponins (cTn) are the most sensitive and specific biochemical markers …

Although guidelines recommend fixed cardiac troponin thresholds for the diagnosis of
myocardial infarction, troponin concentrations are influenced by age, sex, comorbidities and …

Recommendations for the use of cardiac troponin (cTn) measurement in acute cardiac care
have recently been published. 1 Subsequently, a high-sensitivity (hs) cTn T assay was …

Background: The safety of the European Society of Cardiology (ESC) 0/1-h algorithm for
rapid rule-out and rule-in of non–ST-segment elevation myocardial infarction (NSTEMI) …

Background High-sensitivity cardiac troponin (hs-cTn) assays seem to improve the early
diagnosis of acute myocardial infarction (AMI), but it is unknown how to best use them in …

The release of cardiomyocyte components, ie biomarkers, into the bloodstream in higher
than usual quantities indicates an ongoing pathological process. Thus, detection of elevated …

Context Older adults comprise the majority of new-onset heart failure (HF) diagnoses, but
traditional risk-factor prediction models have limited accuracy in this population to identify …

Background—Current guidelines for the diagnosis of acute myocardial infarction (AMI),
among other criteria, also require a rise and/or fall in cardiac troponin (cTn) levels. It is …

Background—It is unknown whether more sensitive cardiac troponin (cTn) assays maintain
their clinical utility in patients with renal dysfunction. Moreover, their optimal cutoff levels in …